BioCentury | Jun 2, 2014
Emerging Company Profile

Panoptes: Dual attack in uveitis

...Corporate partners: 4SC AG Number of employees: 3 Funds raised: €1.2 million ($1.6 million) Investors: aws-Life Science Austria...
BioCentury | Sep 30, 2013
Financial News

Panoptes Pharma completes venture financing

...Austria Business: Ophthalmic Date completed: 9/26/13 Type: Venture financing Raised: €1.2 million ($1.6 million) Investors: aws-Life Science Austria...
BioCentury | Sep 27, 2013
Financial News

Panoptes closes EUR1.2M seed round, in-licenses 4SC compound

...Pharma GmbH (Vienna, Austria) raised EUR 1.2 million ($1.6 million) in a seed round from AWS-Life Science Austria...
Items per page:
1 - 3 of 3
BioCentury | Jun 2, 2014
Emerging Company Profile

Panoptes: Dual attack in uveitis

...Corporate partners: 4SC AG Number of employees: 3 Funds raised: €1.2 million ($1.6 million) Investors: aws-Life Science Austria...
BioCentury | Sep 30, 2013
Financial News

Panoptes Pharma completes venture financing

...Austria Business: Ophthalmic Date completed: 9/26/13 Type: Venture financing Raised: €1.2 million ($1.6 million) Investors: aws-Life Science Austria...
BioCentury | Sep 27, 2013
Financial News

Panoptes closes EUR1.2M seed round, in-licenses 4SC compound

...Pharma GmbH (Vienna, Austria) raised EUR 1.2 million ($1.6 million) in a seed round from AWS-Life Science Austria...
Items per page:
1 - 3 of 3